Amicus Therapeutics, Inc. (FOLD) Insider Ownership

Historic Ownership Trends

Over the 90-day window ending December 12, 2025, Amicus Therapeutics's three dominant insider ownership positions are held by President And CEO Bradley L Campbell (1.14Mn shares), Executive Chairman John F Crowley (573.48K shares), Chief Legal Officer Ellen Rosenberg (507.71K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Bradley L Campbell President And CEO 1,137,282 03 Dec, 2025
John F Crowley Executive Chairman 573,478 05 Mar, 2024
Ellen Rosenberg Chief Legal Officer 507,710 26 Nov, 2025
Hung Do Chief Science Officer 448,617 08 Apr, 2021
Jeff Castelli Chief Development Officer 439,318 26 Nov, 2025
Daphne Quimi Chief Financial Officer 398,532 19 Jan, 2023
David Michael Clark Chief People Officer 296,975 26 Nov, 2025
Simon N.R. Harford Chief Financial Officer 214,898 25 Aug, 2025
Samantha Prout Chief Accounting Officer 141,634 03 Dec, 2025
Burke W Whitman 118,598 06 Jun, 2025
Michael Raab 115,857 06 Jun, 2025
Glenn Sblendorio 115,857 06 Jun, 2025
Lynn Dorsey Bleil 113,941 06 Jun, 2025
Margaret G Mcglynn 91,550 06 Jun, 2025
Craig A Wheeler 84,631 06 Jun, 2025
Eiry Roberts 76,275 06 Jun, 2025
Michael Aaron Kelly 72,468 06 Jun, 2025
Robert Essner 31,115 14 Jun, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
01 Dec, 2025 Bradley L Campbell Common Stock A 14,587 $9.03 1,151,869 D M
01 Dec, 2025 Samantha Prout Common Stock A 32,193 $0.00 141,634 D A
01 Dec, 2025 Bradley L Campbell Common Stock D 14,587 $10.01 1,137,282 D S
24 Nov, 2025 Bradley L Campbell Common Stock A 14,587 $9.03 1,151,869 D M
24 Nov, 2025 Jeff Castelli Common Stock A 50,000 $9.03 515,476 D M
24 Nov, 2025 David Michael Clark Common Stock D 25,643 $10.10 296,975 D S
24 Nov, 2025 Ellen Rosenberg Common Stock A 25,000 $6.10 532,710 D M
24 Nov, 2025 Jeff Castelli Common Stock D 76,158 $10.16 439,318 D S
24 Nov, 2025 Bradley L Campbell Common Stock D 14,587 $10.04 1,137,282 D S
24 Nov, 2025 Ellen Rosenberg Common Stock A 11,000 $5.13 543,710 D M
24 Nov, 2025 Ellen Rosenberg Common Stock D 36,000 $10.06 507,710 D S
25 Nov, 2025 Ellen Rosenberg Common Stock A 36,000 $5.13 543,710 D M
25 Nov, 2025 Ellen Rosenberg Common Stock D 36,000 $10.00 507,710 D S
26 Nov, 2025 Ellen Rosenberg Common Stock A 23,621 $5.13 531,331 D M
26 Nov, 2025 Ellen Rosenberg Common Stock D 23,621 $10.00 507,710 D S
04 Nov, 2025 David Michael Clark Common Stock D 25,643 $9.51 322,618 D S
21 Aug, 2025 Simon N.R. Harford Common Stock D 12,529 $7.60 214,898 D F
21 Aug, 2025 Simon N.R. Harford - - 214,898 D
05 Jun, 2025 Michael Raab Common Stock A 20,414 $0.00 115,857 D A
05 Jun, 2025 Margaret G Mcglynn Common Stock A 20,414 $0.00 91,550 D A